Secretary for Health Prof Lo Chung-mau met a delegation led by Guangdong Provincial Medical Products Administration (GDMPA) General Director Jiang Xiaodong today, with both sides agreeing to further deepen collaboration in relevant areas. Prof Lo said the Hong Kong Special Administrative Region Government expressed its sincere gratitude to the GDMPA for its staunch support for Hong Kong in the past, including the implementation of the initiatives of, among others, the measure of using Hong Kong registered drugs and medical devices used in Hong Kong public hospitals in the Guangdong-Hong Kong-Macao Greater Bay Area and streamlining of the approval procedures for Hong Kong registered traditional proprietary Chinese medicines (pCms) for external use to be registered and sold in the Mainland. The Government and the GDMPA agreed at the meeting to further deepen collaboration on the regulation of Chinese medicines (CM), the formulation of Greater Bay Area Chinese medicine standards,
(To watch the full press briefing with sign language interpretation, click here.)
To cope with a possible rapid surge in confirmed COVID-19 cases, the Hospital Authority today decided to reopen the standby community treatment facility at AsiaWorld-Expo on Sunday to provide 500 beds.
It said facility will receive patients who are asymptomatic or in a relatively stable condition.
If the epidemic deteriorates further, the authority will deploy, in phases, the 1,200 isolation beds and 600 tier-2 isolation beds in public hospitals for the admission of elderly, paediatric and severe patients in particular.
The authority has a stock of personal protective equipment to last more than six months, it added.
In preparation for the treatment of severe patients, there are around 1,500 ventilators in total in various public hospitals.
http://dlvr.it/SGK7KG
http://dlvr.it/SGK7KG